TransThera Sciences (2617)

Currency in HKD
132.70
-6.10(-4.39%)
Closed·
2617 Scorecard
Full Analysis
Stock generally trades with high price volatility
2617 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
132.40145.80
52 wk Range
20.20679.50
Key Statistics
Bid/Ask
132.70 / 132.90
Prev. Close
138.8
Open
143.9
Day's Range
132.4-145.8
52 wk Range
20.2-679.5
Volume
922.5K
Average Volume (3m)
1.72M
1-Year Change
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
2617 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

TransThera Sciences Company Profile

TransThera Sciences (Nanjing), Inc., clinical stage biopharmaceutical company, discovers, develops, and commercializes small molecule therapies for oncology, inflammatory, and cardiometabolic diseases. The company provides Tinengotinib (TT-00420), a MTK inhibitor that is in clinical stage for the treatment of recurrent or refractory drug-resistant solid tumors. It also develops TT-00973, a kinase inhibitor for treating various cancers; TT-01488, a BTK inhibitor for the treatment of B-cell lymphoma; TT-01688, an oral S1P1 modulator for treating various inflammatory diseases; TT-00920, an oral PDE9 inhibitor used for treating central nervous system diseases; TT-01025, an oral irreversible VAP-1 inhibitor designed for the treatment of NASH; and TT-02332, a NLRP3 inhibitor for metabolic and inflammatory diseases. TransThera Sciences (Nanjing), Inc. was formerly known as Nanjing TransThera Biosciences Co. Ltd. and changed its name to TransThera Sciences (Nanjing), Inc. in July 2021. The company was incorporated in 2014 and is headquartered in Nanjing, China.

Compare 2617 to Peers and Sector

Metrics to compare
2617
Peers
Sector
Relationship
P/E Ratio
−203.5x−38.7x−0.7x
PEG Ratio
−11.16−0.520.00
Price/Book
82.9x6.4x2.6x
Price / LTM Sales
-21.2x3.4x
Upside (Analyst Target)
-17.7%35.7%
Fair Value Upside
Unlock−13.2%4.1%Unlock

Earnings

Latest Release
Aug 25, 2025
EPS / Forecast
-0.32 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

2617 Income Statement

People Also Watch

133.50
9888
-1.11%
103.60
3690
-0.10%
262.40
9992
+2.98%

FAQ

What Stock Exchange Does TransThera Sciences Trade On?

TransThera Sciences is listed and trades on the Hong Kong Stock Exchange stock exchange.

What Is the Stock Symbol for TransThera Sciences?

The stock symbol for TransThera Sciences is "2617."

What Is the TransThera Sciences Market Cap?

As of today, TransThera Sciences market cap is 52.67B.

What Is TransThera Sciences's Earnings Per Share (TTM)?

The TransThera Sciences EPS (TTM) is -0.62.

From a Technical Analysis Perspective, Is 2617 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has TransThera Sciences Stock Split?

TransThera Sciences has split 0 times.

How Many Employees Does TransThera Sciences Have?

TransThera Sciences has 0 employees.

What is the current trading status of TransThera Sciences (2617)?

As of 09 Oct 2025, TransThera Sciences (2617) is trading at a price of 132.70, with a previous close of 138.80. The stock has fluctuated within a day range of 132.40 to 145.80, while its 52-week range spans from 20.20 to 679.50.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.